Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

HUTCHMED (China) Ltd (HCM) Profit Margins

Over the twelve months to 2026-06-30, HUTCHMED (China) Ltd (HCM) had gross margin 41.6%, operating margin -6.3%, net margin 3.3%, free cash flow margin 1.8%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

HCMHUTCHMED (China) LtdFollow HCM — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
2.5B
P/E TTM
143.6
Dividend yield
—
52-week
—
Next earnings
—
LineFY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin31.0%29.6%—————54.1%44.6%38.7%41.6%
Operating margin-21.6%-22.1%-43.3%-71.4%-86.3%-92.2%-95.6%2.2%-6.9%-7.1%-6.3%
Net margin5.4%-11.1%-34.9%-51.7%-55.2%-54.7%-84.6%12.0%6.0%83.3%3.3%
FCF margin-6.4%-5.8%-18.3%-43.7%-30.7%-62.0%-71.6%22.3%-2.8%-14.4%1.8%

USD billions · SEC XBRL

HUTCHMED (China) Ltd — questions

What is HUTCHMED (China) Ltd's gross margin?
41.6% over the twelve months to 2026-06-30.
What is HUTCHMED (China) Ltd's operating margin?
-6.3% over the twelve months to 2026-06-30.
What is HUTCHMED (China) Ltd's net profit margin?
3.3% over the twelve months to 2026-06-30.

Every figure on this page comes from HUTCHMED (China) Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.